BUSINESS WIRE--Allurion Technologies, a pioneering leader in the development of innovative, scalable and trusted weight loss experiences, today announces completion of enrollment in ENLIGHTEN, a United States clinical trial for the Elipse® Balloon –a procedureless™ gastric balloon for weight loss. Allurion expects to use the data from this trial in its future regulatory submission to the U.S. Food and Drug Administration (FDA).